Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(17%)

Phase Distribution

Ph phase_2
1
17%
Ph phase_1
5
83%

Phase Distribution

5

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
5(83.3%)
Phase 2Efficacy & side effects
1(16.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Terminated(1)
Other(5)

Detailed Status

unknown5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
0.0%
Most Advanced
Phase 2

Trials by Phase

Phase 15 (83.3%)
Phase 21 (16.7%)

Trials by Status

terminated117%
unknown583%

Recent Activity

0 active trials
Showing 5 of 6
terminatedphase_1

Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression.

NCT03059355
unknownphase_1

Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19)

NCT04346368
unknownphase_1

Effect of BM-MSCs on Chronic AMR After Kidney Transplantation

NCT02563340
unknownphase_1

Effect of BM-MSCs on Early Graft Function Recovery After DCD Kidney Transplant.

NCT02563366
unknownphase_1

Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease

NCT02504437
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT03059355Phase 1

Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression.

Terminated
NCT04346368Phase 1

Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19)

Unknown
NCT02563340Phase 1

Effect of BM-MSCs on Chronic AMR After Kidney Transplantation

Unknown
NCT02563366Phase 1

Effect of BM-MSCs on Early Graft Function Recovery After DCD Kidney Transplant.

Unknown
NCT02504437Phase 1

Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease

Unknown
NCT01720888Phase 2

Intracoronary Autologous Mesenchymal Stem Cells Implantation in Patients With Ischemic Dilated Cardiomyopathy

Unknown

All 6 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
6